triazoles has been researched along with Vestibular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balaban, CD; Furman, JM; Marcus, DA | 1 |
| Cutillas, B; Hernández-Mir, G; Llorens, J; Saldaña-Ruíz, S; Sedó-Cabezón, L | 1 |
| Nawrot, M | 1 |
1 review(s) available for triazoles and Vestibular Diseases
| Article | Year |
|---|---|
Disorders of motion and depth.
Topics: Alzheimer Disease; Amblyopia; Antidepressive Agents; Cerebral Veins; Cues; Depth Perception; Epilepsy; Humans; Mesencephalon; Motion Perception; Occipital Lobe; Perceptual Disorders; Piperazines; Schizophrenia; Sinus Thrombosis, Intracranial; Temporal Lobe; Triazoles; Vestibular Diseases; Williams Syndrome | 2003 |
1 trial(s) available for triazoles and Vestibular Diseases
| Article | Year |
|---|---|
Rizatriptan reduces vestibular-induced motion sickness in migraineurs.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Motion Sickness; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; Vestibular Diseases; Young Adult | 2011 |
1 other study(ies) available for triazoles and Vestibular Diseases
| Article | Year |
|---|---|
Vestibular toxicity of cis-2-pentenenitrile in the rat.
Topics: Animals; Behavior, Animal; Body Weight; Central Nervous System; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Activation; Epithelium; Fluoresceins; Fluorescent Dyes; Hair Cells, Auditory; Male; Microscopy, Electron, Scanning; Motor Activity; Nitriles; Rats; Rats, Long-Evans; Triazoles; Vestibular Diseases; Vestibule, Labyrinth | 2012 |